CervoMed Inc.CRVO

$4.24+0.43 (+11.29%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$39M

Micro-cap

-97%

2016 — today

10-Year Price

-100%

2016 — today

52-Week Range

$2.25$10.69

Current $4.24· 24%

CervoMed Inc., headquartered in Boston, Massachusetts, operates as a clinical-stage biotechnology firm committed to discovering, developing, and ultimately bringing to market pharmaceutical solutions for various neurodegenerative conditions. A central component of their therapeutic pipeline is neflamapimod, an innovative small molecule designed for oral administration and capable of crossing the blood-brain barrier. This compound is currently being advanced as a potential treatment for debilitating ailments such as Lewy body dementia (DLB), Alzheimer's disease, and for aiding recovery following a cerebral stroke.

Valuation in context

P/E ratio

-1.3

N/A

Not meaningful — company is unprofitable

P/B ratio

3.7

Historically pricey

Historically pricey — last 10 years

FCF Yield

-70.2%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when CRVO is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.